(Q41920864)

English

Immunosuppression involving increased myeloid-derived suppressor cell levels, systemic inflammation and hypoalbuminemia are present in patients with anaplastic thyroid cancer

scientific article published on 22 August 2013

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

14 October 2017

Immunosuppression involving increased myeloid-derived suppressor cell levels, systemic inflammation and hypoalbuminemia are present in patients with anaplastic thyroid cancer (English)

1 reference

Europe PubMed Central

PMC publication ID

14 October 2017

immunosuppression

1 reference

based on heuristic

inferred from title

systemic inflammation

1 reference

based on heuristic

inferred from title

author name string

Shinichi Suzuki

1

1 reference

Europe PubMed Central

PMC publication ID

14 October 2017

Masahiko Shibata

2

1 reference

Europe PubMed Central

PMC publication ID

14 October 2017

Kenji Gonda

3

1 reference

Europe PubMed Central

PMC publication ID

14 October 2017

Yasuyuki Kanke

4

1 reference

Europe PubMed Central

PMC publication ID

14 October 2017

Mai Ashizawa

5

1 reference

Europe PubMed Central

PMC publication ID

14 October 2017

Daisuke Ujiie

6

1 reference

Europe PubMed Central

PMC publication ID

14 October 2017

Seiko Suzushino

7

1 reference

Europe PubMed Central

PMC publication ID

14 October 2017

Keiichi Nakano

8

1 reference

Europe PubMed Central

PMC publication ID

14 October 2017

Toshihiko Fukushima

9

1 reference

Europe PubMed Central

PMC publication ID

14 October 2017

Kenichi Sakurai

10

1 reference

Europe PubMed Central

PMC publication ID

14 October 2017

Ryouichi Tomita

11

1 reference

Europe PubMed Central

PMC publication ID

14 October 2017

Kensuke Kumamoto

12

1 reference

Europe PubMed Central

PMC publication ID

14 October 2017

Seiichi Takenoshita

13

1 reference

Europe PubMed Central

PMC publication ID

14 October 2017

publication date

22 August 2013

1 reference

Europe PubMed Central

PMC publication ID

14 October 2017

Molecular and Clinical Oncology

1 reference

Europe PubMed Central

PMC publication ID

14 October 2017

1

1 reference

Europe PubMed Central

PMC publication ID

14 October 2017

6

1 reference

Europe PubMed Central

PMC publication ID

14 October 2017

959-964

1 reference

Europe PubMed Central

PMC publication ID

14 October 2017

Targeting immune suppressing myeloid-derived suppressor cells in oncology.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3915656

5 June 2018

Cancer and inflammation: implications for pharmacology and therapeutics

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3915656

5 June 2018

Myeloid-derived suppressor cells: linking inflammation and cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3915656

5 June 2018

Myeloid-derived suppressor cells as regulators of the immune system

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3915656

5 June 2018

Increased circulating myeloid-derived suppressor cells correlate with clinical cancer stage, metastatic tumor burden, and doxorubicin-cyclophosphamide chemotherapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3915656

5 June 2018

Arginase, prostaglandins, and myeloid-derived suppressor cells in renal cell carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3915656

5 June 2018

Cancer immunotherapy: moving beyond current vaccines

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3915656

5 June 2018

C-reactive protein and the risk of incident colorectal cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3915656

5 June 2018

Inflammation and cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3915656

5 June 2018

Interleukin-10 and the interleukin-10 receptor

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3915656

5 June 2018

Anaplastic thyroid carcinoma: current diagnosis and treatment

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3915656

5 June 2018

Anaplastic thyroid carcinoma: behavior, biology, and therapeutic approaches.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3915656

5 June 2018

The epidemiology of thyroid carcinoma.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3915656

5 June 2018

Anaplastic thyroid carcinoma producing the granulocyte colony stimulating factor (G-CSF): report of a case

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3915656

5 June 2018

Establishment of a human undifferentiated thyroid cancer cell line producing several growth factors and cytokines

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3915656

5 June 2018

The results of various modalities of treatment of well differentiated thyroid carcinomas: a retrospective review of 1599 patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3915656

5 June 2018

Anaplastic thyroid carcinoma with prominent cardiac metastasis, accompanied by a marked leukocytosis with a neutrophilia and high GM-CSF level in serum

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3915656

5 June 2018

Circulating myeloid-derived suppressor cells are increased and correlate to immune suppression, inflammation and hypoproteinemia in patients with cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3915656

18 August 2018

Preoperative circulating C-reactive protein levels predict pathological aggressiveness in oral squamous cell carcinoma: a retrospective clinical study.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3915656

18 August 2018

Baseline C-reactive protein is associated with incident cancer and survival in patients with cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3915656

18 August 2018

Circulating levels of inflammatory markers and cancer risk in the health aging and body composition cohort.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3915656

18 August 2018

Arginase-producing myeloid suppressor cells in renal cell carcinoma patients: a mechanism of tumor evasion

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3915656

18 August 2018

Natural history, treatment, and course of papillary thyroid carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3915656

18 August 2018

Cancer immunotherapy: breaking the barriers to harvest the crop

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3915656

2 December 2018

Prognosis in thyroid carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/24649277

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.3892/MCO.2013.170

1 reference

Europe PubMed Central

PMC publication ID

14 October 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

14 October 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

14 October 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q41920864&oldid=1929898341"